Effects of Lysophospholipid Supplementation in Feed with Low Protein or Lipid on Growth Performance, Lipid Metabolism, and Intestinal Flora of Largemouth Bass (Micropterus salmoides).

The largemouth bass (Micropterus salmoides) were fed diets with three experimental feeds, a control diet (Control, crude protein (CP): 54.52%, crude lipid (CL): 11.45%), a low-protein diet with lysophospholipid (LP-Ly, CP: 52.46%, CL: 11.36%), and a low-lipid diet with lysophospholipid (LL-Ly, CP: 54.43%, CL: 10.19%), respectively. The LP-Ly and LL-Ly groups represented the addition of 1 g/kg of lysophospholipids in the low-protein and low-lipid groups, respectively. After a 64-day feeding trial, the experimental results showed that the growth performance, hepatosomatic index, and viscerosomatic index of largemouth bass in both the LP-Ly and LL-Ly groups were not significantly different compared to those in the Control group (P > 0.05). The condition factor and CP content of whole fish were significantly higher in the LP-Ly group than those in the Control group (P < 0.05). Compared with the Control group, the serum total cholesterol level and alanine aminotransferase enzyme activity were significantly lower in both the LP-Ly group and the LL-Ly group (P < 0.05). The protease and lipase activities in the liver and intestine of both group LL-Ly and group LP-Ly were significantly higher than those of the Control group (P < 0.05). Compared to both the LL-Ly group and the LP-Ly group, significantly lower liver enzyme activities and gene expression of fatty acid synthase, hormone-sensitive lipase, and carnitine palmitoyltransferase 1 were found in the Control group (P < 0.05). The addition of lysophospholipids increased the abundance of beneficial bacteria (Cetobacterium and Acinetobacter) and decreased the abundance of harmful bacteria (Mycoplasma) in the intestinal flora. In conclusion, the supplementation of lysophospholipids in low-protein or low-lipid diets had no negative effect on the growth performance of largemouth bass, but increased the activity of intestinal digestive enzymes, enhanced the hepatic lipid metabolism, promoted the protein deposition, and regulated the structure and diversity of the intestinal flora.

Dietary lysophospholipids improves growth performance and hepatic lipid metabolism of largemouth bass (Micropterussalmoides).

This study was conducted to evaluate the influence of dietary lysophospholipids combined with 1% dietary fish oil reduction on the growth performance and hepatic lipid metabolism of largemouth bass (Micropterus salmoides). Five isonitrogenous feeds were prepared with lysophospholipids at 0% (fish oil group, FO), 0.05% (L-0.05), 0.1% (L-0.1), 0.15% (L-0.15) and 0.2% (L-0.2), respectively. The dietary lipid was 11% in the FO diet and 10% in the other diets. Largemouth bass were fed for 68 d (initial body weight = 6.04 ± 0.01 g) with 4 replicates per group and 30 fish per replicate. The results showed that the fish fed diet containing 0.1% lysophospholipids had higher digestive enzyme activity and obtained better growth performance compared to the fish fed FO diet (P < 0.05). The feed conversion rate in the L-0.1 group was significantly lower than that in the other groups. Serum total protein and triglyceride contents in L-0.1 group were significantly higher than those in other groups (P < 0.05) and the contents of total cholesterol and low-density lipoprotein cholesterol in L-0.1 group were significantly lower than those in FO group (P < 0.05). The activity and genes expression of hepatic glucolipid metabolizing enzymes in L-0.15 group were significantly increased compared to those in FO group (P < 0.05). Reducing 1% fish oil along with 0.1% lysophospholipids added to the feed could improve the digestion and absorption of nutrients, enhance the activity of liver glycolipid metabolizing enzymes, and thus effectively promote the growth of largemouth bass.

Evolution of magnetic phase in two-dimensional van der Waals Mn1-xNixPS3single crystals.

Metal thio(seleno)phosphatesMPX3have attracted considerable attentions with wide spanned band gaps and rich magnetic properties. In this series, two neighboring members MnPS3and NiPS3differ in magnetic atoms, magnetic easy axes, spin anisotropy, as well as nearest-neighbor magnetic interactions. The competition between these components may cause intriguing physical phenomena. In this article, the evolution of magnetism of Mn1-xNixPS3series is reported. Despite the incompatible antiferromagnetic orders of two end members, the antiferromagnetism persists as the ground state in the whole substitution region. The magnetic ordering temperatureTNshow nonmonotonic V-shape behavior, and the reentrant spin glass phase atx= 0.5 is observed. In addition, abnormal bifurcation ofTNoccurs atx= 0.75, which may be due to the temperature-dependent spin reorientation or phase separation. The evolution of magnetism is further confirmed semi-quantitatively by our density functional theory calculations. Our study indicates that exotic magnetism can be intrigued when multi-degrees of freedom are involved in these low-dimensional systems, which call for more in-depth microscopic studies in future.

piRNA-823 Is Involved in Cancer Stem Cell Regulation Through Altering DNA Methylation in Association With Luminal Breast Cancer.

Cancer stem cells (CSCs) are believed to be the main source of cancer relapse and metastasis. PIWI-interacting small non-coding RNAs (piRNAs) have been recently recognized to be relevant to cancer biology. Whether and how piRNAs regulate human CSCs remain unknown. Herein, upregulation of piR-823 was identified in tested luminal breast cancer cells, especially in the luminal subtype of breast CSCs. Enforced expression or targeted knockdown of piR-823 demonstrated its oncogenic function in regulating cell proliferation and colony formation in MCF-7 and T-47D breast cancer cells. In addition, piR-823 induced ALDH (+) breast CSC subpopulation promoted the expression of stem cell markers including OCT4, SOX2, KLF4, NANOG, and hTERT, and increased mammosphere formation. Tail vein injection of magnetic nanoparticles carrying anti-piR-823 into the mammary gland of tumor-burdened mice significantly inhibited tumor growth in vivo. DNA methyltransferases (DNMTs) including DNMT1, DNMT3A, and DNMT3B were demonstrated to be the downstream genes of piR-823, which regulate gene expression by maintaining DNA methylation. piR-823 increased the expression of DNMTs, promoted DNA methylation of gene adenomatous polyposis coli (APC), thereby activating Wnt signaling and inducing cancer cell stemness in the luminal subtype of breast cancer cells. The current study not only revealed a novel mechanism through which piRNAs contribute to tumorigenesis in breast cancer by regulating CSCs, but also provided a therapeutic strategy using non-coding genomes in the suppression of human breast cancer.